Hims & Hers Health (HIMS) Total Debt Growth (3y) (2022 - 2023)

Hims & Hers Health (HIMS) Total Debt Growth (3y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -2.21%
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -7.03%
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 11.29%
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 63.29%
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -7.76%
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn -
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -14.15%
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 157.05%
Jun 30, 2023 112.84%
Jun 30, 2022 510.95%